Article

Recovering from Ankle Surgery? Take a Break from Driving

Patients recovering from a right foot injury or surgery take much longer to brake when the driver is wearing an immobilization device.

According to a new study from the Journal of Bone and Joint Surgery (JBJS), it takes much longer to brake when the driver is wearing an immobilization device like a splint or brace, than it does when wearing normal footwear.

Driving is important to many people's social and professional lives, so when a person's right ankle or foot must be immobilized after an injury or surgery, one of the first questions an orthopaedic surgeon hears is, "When can I start driving again?"

To answer this question, researchers measured emergency braking time in people using a brake adapted for use by the left foot, or wearing a short leg cast, a controlled ankle-motion boot, or normal footwear. The results showed that all of the devices, except for normal footwear, impaired the drivers' ability to brake quickly.

"We did not find a device that was as safe as normal footwear," said CPT Thomas Dowd, MD, an orthopaedic surgeon in the Department of Orthopedics and Rehabilitation at Brooke Army Medical Center in Fort Sam Houston, Texas, through a press release. "We only tested emergency braking situations, but it's reasonable to assume that if a person cannot stop quickly in an emergency, it may not be safe for that person to be driving."

Study details and findings:

- Compared with an individual wearing normal footwear, an individual traveling at 60 mph would travel an additional 9.2 feet during emergency braking when wearing a right lower-extremity controlled-ankle-motion boot.

- A driver wearing a right lower-extremity short leg cast would travel an additional 6.1 feet before coming to an emergency stop.

- A driver using a left-foot braking adapter would travel an additional 6.0 feet

- At a driving speed of 35 mph the same individuals would travel an additional 5.4 feet, 3.6 ft, and 3.5 feet, respectively. These changes in distance traveled might represent the difference between being involved in or avoiding a collision in an emergency setting.

- The effect of immobilization devices on fine braking scenarios such as navigating a curve or driving in stop-and-go traffic is unknown, but according to study authors, it is likely to be greater.

- The test subjects were healthy adults who had not recently undergone surgery or sustained an injury, so their braking response times are likely to be somewhat better than individuals having discomfort or other symptoms due to their medical condition.

"Based on our findings," Dowd said, "we cannot recommend that any patient return to driving using a brake adapter or wearing an immobilization device on the right foot. Orthopaedic surgeons need to educate their patients about these safety concerns when discussing the best time to begin driving again."

Other relevant facts and statistics noted in the study:

- The ability to perform an emergency stop is essential for safe driving and can be represented by total brake-response time, reaction time, and braking time.

- Survey studies indicated that more than 90% of orthopaedic surgeons would generally not recommend that a patient drive while immobilized in a right lower-extremity short leg cast.

- Under the terms of most insurance policies, the insurer is not obligated to cover accidents in which the driver was still recovering from an earlier injury or operation.

Source: American Academy of Orthopaedic Surgeons

--Will you take these findings into consideration? Leave a comment.

Related Videos
Kimberly A. Davidow, MD: Elucidating Risk of Autoimmune Disease in Childhood Cancer Survivors
Matthew J. Budoff, MD: Examining the Interplay of Coronary Calcium and Osteoporosis | Image Credit: Lundquist Institute
Orrin Troum, MD: Accurately Imaging Gout With DECT Scanning
John Stone, MD, MPH: Continuing Progress With IgG4-Related Disease Research
AMG0001 Advances Healing in CLTI with David G. Armstrong, DPM, PhD, and Michael S. Conte, MD | Image Credit: Canva
Philip Conaghan, MBBS, PhD: Investigating NT3 Inhibition for Improving Osteoarthritis
Rheumatologists Recognize the Need to Create Pediatric Enthesitis Scoring Tool
Presence of Diffuse Cutaneous Disease Linked to Worse HRQOL in Systematic Sclerosis
Alexei Grom, MD: Exploring Safer Treatment Options for Refractory Macrophage Activation Syndrome
Jack Arnold, MBBS, clinical research fellow, University of Leeds, Leeds Institute of Rheumatic and Musculoskeletal Medicine
© 2024 MJH Life Sciences

All rights reserved.